← All trials
NCT04869449
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2022
- Primary completion
- May 31, 2023
- Completion date
- May 31, 2023
- First posted
- May 3, 2021
- Last posted
- Nov 10, 2021
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pennsylvania State UniversityLead sponsor
- Pennsylvania State UniversityReponsible party - principal investigator
- Pennsylvania State UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.